People

Keith Kennedy to Assume Dual Role at CareDx

Kennedy has more than 20 years of experience and executive leadership in healthcare.

By: Michael Barbella

Managing Editor

Keith Kennedy. Headshot: CareDx Inc.

CareDx Inc. Chief Operating Officer (COO) Keith Kennedy has earned a new (additional) title.

Besides his COO duties, Kennedy also will undertake the responsibilities of chief financial officer (CFO), succeeding Nathan Smith, the company announced.

Kennedy has more than 20 years of healthcare and executive leadership experience, including global diagnostics, biopharma services, and contract development and manufacturing organization (CDMO). Kennedy has served as CareDx’s COO since September 2024.

Before joining CareDx, Kennedy was CFO at PharmaLogic Holdings Corp from April 2022 to September 2024. At Veracyte, Kennedy served in various roles from December 2016 to May 2021, including as COO, CFO, and secretary. Kennedy also held key executive positions at MCG Capital Corporation and GE Capital.

Kennedy was a U.S. Air Force officer and earned a bachelor of science degree in accounting with high distinction from Indiana University and an MBA from the College of William & Mary. Kennedy is a chartered financial analyst and certified public accountant.

CareDx is a precision medicine company striving to improve outcomes for transplant patients and advance organ health. The company’s integrated solutions include non‑invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx provides genomics‑based information for transplant patients.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters